Mr. Stoner is the director of the Idaho Accelerator Center (IAC), a research institute of Idaho State University. He has been researching isotope production using linear accelerators for 14 years and pioneered a new process and mechanism for producing therapeutic copper-67 that enables it to be manufactured in the quantities and quality required for clinical development. He has 10 years of experience in production of the copper-67 isotope, and under his leadership the IAC has been shipping copper-67 commercially since 2014, supporting Clarity’s Targeted Copper Theranostic programs from preclinical through to the clinic where there are now three therapy products in clinical development.
Mr. Stoner has 3 patents on the production of copper-67 and has 11 related publications. He has worked in many technical and business roles in high technology for more than 34 years including Sr. VP and Chief Technology Officer of AMI Semiconductor where he was responsible for worldwide R&D and Intellectual Property, General Manager of the Image Sensor Business Unit and Founder and Managing Partner of C&J Tech Consulting – a company supplying technical evaluation support to Private Equity investors and other clients.